Innovating Works

VIROCLINICS

Desconocido
Inno4Vac: Innovations to accelerate vaccine development and manufacture VIROCLINICS BIOSCIENCES BV participó en un H2020: H2020-JTI-IMI2-2020-20-two-stage Inno4Vac proposes an ambitious programme that will harness the latest advances in immunology, disease modelling, and modelling for tackling...
2021-07-19 - 2027-02-28 | Financiado
INDIGO: Effective and Affordable Flu Vaccines for the World VIROCLINICS BIOSCIENCES BV participó en un H2020: H2020-SC1-BHC-2018-2020 Despite the availability of flu vaccines for decades, influenza is still an important disease in both developing and developed countries wit...
2019-12-13 - 2025-03-31 | Financiado
ZAPI: Zoonotic Anticipation and Preparedness Initiative VIROCLINICS BIOSCIENCES BV participó en un FP6: Emerging infectious diseases are occurring at increasing frequency in Europe and other regions of the world, having profound impacts on publ...
2015-03-01 - 2020-02-29 | Financiado
EMPERIE: European Management Platform for Emerging and Re emerging Infectious disease Entities VIROCLINICS BIOSCIENCES BV participó en un FP7: The EMPERIE (European Management Platform for Emerging and Re-emerging Infectious disease Entities) consortium has its roots in the lessons...
Financiado
ZAPI: Zoonotic Anticipation and Preparedness Initiative VIROCLINICS BIOSCIENCES BV participó en un FP7: Emerging infectious diseases are occurring at increasing frequency in Europe and other regions of the world, having profound impacts on publ...
Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.